首页> 外文期刊>BMC Geriatrics >Economic evaluation of an extended nutritional intervention in older Australian hospitalized patients: a randomized controlled trial
【24h】

Economic evaluation of an extended nutritional intervention in older Australian hospitalized patients: a randomized controlled trial

机译:对澳大利亚老年住院患者进行扩展营养干预的经济评估:一项随机对照试验

获取原文
           

摘要

Prevalence of malnutrition in older hospitalized patients is 30%. Malnutrition is associated with poor clinical outcomes in terms of high morbidity and mortality and is costly for hospitals. Extended nutrition interventions improve clinical outcomes but limited studies have investigated whether these interventions are cost-effective. In this randomized controlled trial, 148 malnourished general medical patients ≥60?years were recruited and randomized to receive either an extended nutritional intervention or usual care. Nutrition intervention was individualized and started with 24?h of admission and was continued for 3?months post-discharge with a monthly telephone call whereas control patients received usual care. Nutrition status was confirmed by Patient generated subjective global assessment (PG-SGA) and health-related quality of life (HRQoL) was measured using EuroQoL 5D (EQ-5D-5?L) questionnaire at admission and at 3-months follow-up. A cost-effectiveness analysis was conducted for the primary outcome (incremental costs per unit improvement in PG-SGA) while a cost-utility analysis (CUA) was undertaken for the secondary outcome (incremental costs per quality adjusted life year (QALY) gained). Nutrition status and HRQoL improved in intervention patients. Mean per included patient Australian Medicare costs were lower in intervention group compared to control arm (by $907) but these differences were not statistically significant (95% CI: -$2956 to $4854). The main drivers of higher costs in the control group were higher inpatient ($13,882 versus $13,134) and drug ($838 versus $601) costs. After adjusting outcomes for baseline differences and repeated measures, the intervention was more effective than the control with patients in this arm reporting QALYs gained that were higher by 0.0050 QALYs gained per patient (95% CI: -0.0079 to 0.0199). The probability of the intervention being cost-effective at willingness to pay values as low as $1000 per unit improvement in PG-SGA was >?98% while it was 78% at a willingness to pay $50,000 per QALY gained. This health economic analysis suggests that the use of extended nutritional intervention in older general medical patients is likely to be cost-effective in the Australian health care setting in terms of both primary and secondary outcomes. ACTRN No. 12614000833662 . Registered 6 August 2014.
机译:老年住院患者的营养不良患病率为30%。就高发病率和死亡率而言,营养不良与不良的临床预后相关,并且对医院而言代价高昂。扩大营养干预措施可改善临床效果,但有限的研究调查了这些干预措施是否具有成本效益。在这项随机对照试验中,招募了148名≥60岁的营养不良的普通内科患者,并随机接受了长期营养干预或常规护理。营养干预是个性化的,从入院24小时开始,出院后持续3个月,每月打电话一次,而对照患者则接受常规护理。在入院时和随访3个月时,通过患者产生的主观整体评估(PG-SGA)确认营养状况,并使用EuroQoL 5D(EQ-5D-5?L)调查表测量与健康相关的生活质量(HRQoL) 。对主要结果(PG-SGA中每单位改进的增量成本)进行了成本-效果分析,而对次要结果(获得的每质量调整生命年(QALY)的增量成本)进行了成本-效用分析(CUA), 。干预患者的营养状况和HRQoL改善。与对照组相比,干预组的平均每位患者澳大利亚联邦医疗保险费用较低(降低了907澳元),但差异无统计学意义(95%CI:-2956至4854澳元)。对照组中较高成本的主要动因是住院成本(13,882美元对13,134美元)和药物成本(838美元对601美元)的增加。在针对基线差异调整结果并重复测量后,该干预措施比对照组更有效,该组患者报告的QALY获得了每位患者0.0050 QALY(95%CI:-0.0079至0.0199)。如果愿意为PG-SGA的每单位改进支付低至1000美元的价值,干预措施具有成本效益,则≥98%,而愿意为每获得的QALY支付50,000美元,则为78%。这项健康经济分析表明,就澳大利亚的初级卫生保健和次级卫生保健结局而言,在澳大利亚的普通医疗患者中使用扩展的营养干预措施可能具有成本效益。 ACTRN号12614000833662。 2014年8月6日注册。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号